Skip to content
Search

Latest Stories

Cathy Harrison assumes permanent role as Northern Ireland's Chief Pharmaceutical Officer

Cathy Harrison has been permanently appointed as Northern Ireland's Chief Pharmaceutical Officer.

Harrison, who had been serving as the acting CPO since Dr Mark Timoney stepped down in December 2018, took up her permanent role last week.


She is responsible for leading policy relating to Medicines Optimisation, Innovation, Pharmacist Prescribing, Pharmacy in the Community and Pharmaceutical Public Health.

A qualified pharmacist, Harrison is the registrant of both the Pharmaceutical Society of Northern Ireland and the Royal Pharmaceutical Society of Great Britain.

Speaking at an National Pharmacy Association (NPA) reception in Belfast on Monday, Harrison said the pharmacists’ “skills are increasingly in demand.”

In her first public speech since taking over as permanent CPO, she warned that “pharmacy cannot be the answer to every question” and urged the NPA members to focus on what they do best and make the most of their medicinal expertise.

Harrison also envisaged a positive future for community pharmacy.

Also speaking at the event, Gerard Greene, Chief Executive of Community Pharmacy Northern Ireland said Community pharmacy was “intent on making significant in-roads into the public health, medicines optimisation and transformation agendas”.

NPA Acting Chair Andrew Lane, who hosted the reception, praised both Harrison and Greene for maintaining a constructive dialogue with each other through trying times, noting pressures on workforce and finances.

Co-host Michael Guerin, the NPA’s Treasurer, said he now looked forward to progress in relation to the long-stalled community pharmacy contract in Northern Ireland.

NPA Chief Executive Mark Lyonette also attended the reception.

More For You

GP surgery upgrades for annual appointments

The surgeries will have additional space to “see more patients, boost productivity and improve patient care”

Pic credit: iStock

GP surgery upgrades to create 8.3 million more annual appointments

Over 1,000 GP surgeries will have their premises modernised to meet the needs of a further 8.3 million appointments each year, the government has announced.

Backed by a cash injection of over £102 million, the surgeries will have additional space to “see more patients, boost productivity and improve patient care”.

Keep ReadingShow less
Wales boosts funding for pharmacy-led UTI and sore throat test services

The sore throat test (STTT) and treat service will be widely available

Pic credit: istock

Welsh pharmacies receive funding boost for clinical services

Two key clinical services will be available in 99 per cent of community pharmacies across Wales after a boost in funding.

The sore throat test (STTT) and treat service and the urinary tract infection (UTI) service have both benefitted from contractual negotiations between the Welsh Government and Community Pharmacy Wales (CPW).

Keep ReadingShow less
Paul Bennett
Paul Bennett, CEO, Royal Pharmaceutical Society
Paul Bennett, CEO, Royal Pharmaceutical Society

Pharmacists need to take advantage of independent prescribing pathways, says Bennett

Independent prescribing will be a “significant point” in the history of community pharmacy, according to Royal Pharmaceutical Society chief executive Paul Bennett.

Last month, the RPS announced the launch of a comprehensive new prescribing development programme to support pharmacists across all stages of their prescribing careers.

Keep ReadingShow less
Community Pharmacy Scotland secures £10m reimbursement uplift amid ongoing negotiations

Negotiations continue on the Global Sum element of remuneration.

Getty Images

Community Pharmacy Scotland secures £120m reimbursement deal for 2025/26

Community Pharmacy Scotland (CPS) has accepted the Scottish government’s initial financial offer for the 2025/26 fiscal year, securing a guaranteed minimum reimbursement of £120 million for community pharmacies — up from £110 million from 2024/25.

The agreement marks the first phase of ongoing negotiations surrounding community pharmacy funding for the upcoming financial year.

Keep ReadingShow less